Haiwei Du
Harbin Medical University(CN)Peking University(CN)Peking University Cancer Hospital(CN)First Affiliated Hospital of Harbin Medical University(CN)US Biologic (United States)(US)Northwest A&F University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65)(2015)61 cited
- → Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer(2021)51 cited
- → Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients(2021)43 cited
- → Elevated myocardial SORBS2 and the underlying implications in left ventricular noncompaction cardiomyopathy(2020)37 cited
- → Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma(2018)35 cited
- → Management of difficult or failed biliary access in initial ERCP: A review of current literature(2018)34 cited